Danaher Corporation $DHR Stock Sold by Curated Wealth Partners LLC

Curated Wealth Partners LLC cut its position in shares of Danaher Corporation (NYSE:DHR) by 96.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 8,883 shares of the conglomerate’s stock after selling 241,076 shares during the quarter. Curated Wealth Partners LLC’s holdings in Danaher were worth $1,968,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Veery Capital LLC lifted its stake in shares of Danaher by 3.1% during the 3rd quarter. Veery Capital LLC now owns 1,581 shares of the conglomerate’s stock valued at $350,000 after buying an additional 48 shares in the last quarter. Studio Investment Management LLC boosted its holdings in Danaher by 3.3% in the 2nd quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock worth $302,000 after buying an additional 51 shares during the period. JDH Wealth Management LLC grew its stake in Danaher by 4.5% in the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock valued at $240,000 after buying an additional 55 shares in the last quarter. OLD Second National Bank of Aurora grew its stake in Danaher by 0.5% in the 1st quarter. OLD Second National Bank of Aurora now owns 12,114 shares of the conglomerate’s stock valued at $2,297,000 after buying an additional 57 shares in the last quarter. Finally, Adelphi Trust Co raised its holdings in Danaher by 2.5% during the 3rd quarter. Adelphi Trust Co now owns 2,365 shares of the conglomerate’s stock valued at $524,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on DHR. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Wells Fargo & Company cut their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. The Goldman Sachs Group lifted their target price on Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a report on Monday, September 21st. Barclays raised their price objective on shares of Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. Finally, Royal Bank Of Canada boosted their price target on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a research report on Monday, October 5th. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $235.41.

More Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Strategic NVIDIA collaboration: Danaher and NVIDIA are combining NVIDIA’s accelerated-computing and AI technologies with Danaher’s scientific instruments, laboratory automation, workflow software and life-sciences expertise. The initiative is intended to advance autonomous science and accelerate drug discovery and other laboratory research, potentially supporting long-term growth in Danaher’s life-sciences businesses. Danaher Collaborates with NVIDIA to Advance Autonomous Science
• Positive Sentiment: AI-powered laboratory expansion: Danaher reportedly plans to launch its first AI-powered autonomous laboratory, with commercial-scale operations targeted for early 2027. Although the announcement had limited immediate market impact, it reinforces the company’s positioning in laboratory automation and AI-enabled scientific workflows. How to Invest in AI Drug Discovery
• Positive Sentiment: Potential earnings beat: Zacks reports that Danaher has a strong earnings-surprise history and currently has favorable Earnings ESP and consensus-estimate factors for its next quarterly report. Analysts expect earnings growth, which may support sentiment ahead of the results. Will Danaher Beat Estimates Again in Its Next Earnings Report?
• Neutral Sentiment: Upcoming earnings remain the key catalyst: Danaher is projected to announce quarterly results on Wednesday. The current reports point to a possible beat, but they do not provide new reported financial results; the stock’s next move will depend on actual revenue, earnings and forward guidance. Danaher Projected to Announce Earnings

Danaher Trading Up 3.0%

DHR stock traded up $6.82 during midday trading on Thursday, hitting $231.51. The company had a trading volume of 2,475,640 shares, compared to its average volume of 4,446,832. The stock has a market cap of $162.75 billion, a price-to-earnings ratio of 41.09, a PEG ratio of 2.80 and a beta of 0.76. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock’s 50 day moving average price is $212.92 and its 200 day moving average price is $195.39. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, equities research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s payout ratio is presently 28.42%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.